ESR1 and breast carcinoma: Induces apoptosis, inhibits cell proliferation in human melanoma and breast cancer cells, reduces DNA damage, inhibits cancer cell migration, and shows antiproliferative and cytotoxic effects on estrogen receptor-positive mammary cells (15, 24, 55).